Van Berkom & Associates’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.4M Sell
165,088
-9,781
-6% -$4.19M 2.03% 29
2025
Q4
$74.8M Buy
174,869
+4,056
+2% +$1.77M 2.16% 27
2025
Q3
$76.5M Buy
170,813
+42,390
+33% +$19.2M 2.21% 21
2025
Q2
$62.5M Buy
128,423
+20,436
+19% +$11.6M 1.86% 35
2025
Q1
$66.4M Sell
107,987
-20,482
-16% -$11.6M 2.13% 26
2024
Q4
$68.1M Sell
128,469
-7,214
-5% -$4.07M 2.02% 30
2024
Q3
$81.5M Buy
135,683
+5,723
+4% +$3.24M 2.24% 22
2024
Q2
$70.5M Buy
129,960
+14,141
+12% +$8.1M 2.11% 26
2024
Q1
$74.3M Sell
115,819
-2,726
-2% -$1.66M 2.12% 32
2023
Q4
$69.3M Sell
118,545
-11,467
-9% -$6.42M 2.02% 33
2023
Q3
$67.6M Buy
130,012
+20,092
+18% +$10.4M 2.2% 27
2023
Q2
$59.5M Sell
109,920
-1,419
-1% -$776K 2.16% 30
2023
Q1
$59.9M Buy
111,339
+6,532
+6% +$3.33M 2.21% 20
2022
Q4
$53.5M Sell
104,807
-2,003
-2% -$975K 2.29% 21
2022
Q3
$46.6M Sell
106,810
-1,255
-1% -$604K 2.22% 22
2022
Q2
$50.7M Sell
108,065
-2,301
-2% -$1.12M 2.12% 28
2022
Q1
$55.9M Sell
110,366
-11,759
-10% -$5.64M 2.01% 27
2021
Q4
$64.6M Sell
122,125
-2,277
-2% -$1.09M 1.91% 33
2021
Q3
$57.9M Sell
124,402
-10,695
-8% -$5.04M 1.75% 35
2021
Q2
$64.1M Sell
135,097
-38,810
-22% -$18.6M 1.76% 32
2021
Q1
$80M Sell
173,907
-10,411
-6% -$5.1M 1.75% 32
2020
Q4
$98.2M Sell
184,318
-661
-0.4% -$325K 2.25% 26
2020
Q3
$88.9M Sell
184,979
-1,076
-0.6% -$528K 2.58% 15
2020
Q2
$83.9M Sell
186,055
-13,927
-7% -$6.22M 2.46% 17
2020
Q1
$86.6M Sell
199,982
-9,439
-5% -$4.22M 3.1% 8
2019
Q4
$92M Buy
209,421
+332
+0.2% +$140K 2.49% 12
2019
Q3
$87.3K Sell
209,089
-42,843
-17% -$17.5M 2.14% 10
2019
Q2
$90.9M Sell
251,932
-1,139
-0.5% -$381K 2.63% 10
2019
Q1
$81M Sell
253,071
-3,663
-1% -$1.12M 2.57% 10
2018
Q4
$72.7M Sell
256,734
-9,259
-3% -$2.79M 2.57% 9
2018
Q3
$85M Sell
265,993
-5,809
-2% -$1.85M 2.41% 11
2018
Q2
$87.5M Sell
271,802
-74,581
-22% -$23.3M 2.54% 5
2018
Q1
$94.5M Sell
346,383
-35,587
-9% -$9.43M 2.87% 4
2017
Q4
$92.8M Sell
381,970
-13,100
-3% -$2.98M 3.03% 2
2017
Q3
$79.8M Sell
395,070
-49,762
-11% -$9.78M 2.87% 4
2017
Q2
$91M Sell
444,832
-22,704
-5% -$4.52M 3.3% 3
2017
Q1
$85.4M Buy
467,536
+2,260
+0.5% +$394K 3.2% 3
2016
Q4
$74.6M Sell
465,276
-8,860
-2% -$1.3M 3% 3
2016
Q3
$66.9M Buy
474,136
+26,040
+6% +$3.63M 2.84% 4
2016
Q2
$61.1M Buy
448,096
+24,104
+6% +$3.2M 2.79% 5
2016
Q1
$57.4M Buy
423,992
+35,678
+9% +$4.82M 2.61% 7
2015
Q4
$58.2M Sell
388,314
-19,579
-5% -$2.89M 2.87% 5
2015
Q3
$54.4M Sell
407,893
-96,777
-19% -$13.5M 2.72% 5
2015
Q2
$66.2M Sell
504,670
-44,310
-8% -$5.48M 3.13% 2
2015
Q1
$65.5M Buy
548,980
+110
+0% +$12.2K 2.98% 3
2014
Q4
$58M Sell
548,870
-4,417
-0.8% -$467K 2.8% 6
2014
Q3
$56.9M Buy
553,287
+12,682
+2% +$1.29M 2.85% 5
2014
Q2
$50.7M Sell
540,605
-33,251
-6% -$2.95M 2.77% 8
2014
Q1
$51.3M Sell
573,856
-113,330
-16% -$9.23M 2.89% 7
2013
Q4
$52.7M Buy
687,186
+114,151
+20% +$8.42M 2.95% 8
2013
Q3
$41M Buy
573,035
+47,983
+9% +$3.41M 2.64% 14
2013
Q2
$38M Buy
+525,052
New +$38.5M 2.85% 9

Other funds holding CHE

Van Berkom & Associates's CHE Position: Q1 2026 in Review

Van Berkom & Associates reduced its Chemed (CHE) stake by 5.6% in Q1 2026, selling an estimated $4.19M and leaving 165,088 shares worth $62.4M. The position accounts for 2.03% of the portfolio, ranked #29.

Van Berkom & Associates first reported a position in CHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.2M in Q4 2020. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Van Berkom & Associates held 165,088 shares of Chemed worth $62.4M as of Q1 2026.
  • Van Berkom & Associates sold 9,781 Chemed shares in Q1 2026, an estimated $4.19M.
  • Chemed made up 2.03% of Van Berkom & Associates's portfolio in Q1 2026, its #29 holding.
  • Van Berkom & Associates first reported a position in Chemed in Q2 2013 and has held it in 52 quarters since.
  • Van Berkom & Associates's Chemed position peaked at $98.2M in Q4 2020.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Van Berkom & Associates's 13F filing for Q1 2026, filed 7 May 2026.